Clinical Trials in Detroit

Showing 15881-15900 of 19,719 trials

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

NCT00129623

This 2 arm study will evaluate the efficacy and safety of oral Bonviva 150mg once monthly compared with placebo in post-menopausal women with osteopenia. Patients will be randomized to receive either Bonviva 150mg po monthly, or placebo monthly. The anticipated time on study treatment is 1-2 years, and the target sample size is 100-500 individuals.

Post-Menopausal Osteopenia

Hoffmann-La Roche160 participantsStarted Dec 2005

Lakewood, Colorado, United States • Stuart, Florida, United States • Bethesda, Maryland, United States +9 more locations

COMPLETEDPhase 2< 1 mile

S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin

NCT00234039

RATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving gemcitabine directly into the bladder may kill more tumor cells. PURPOSE: This phase II trial is studying how well gemcitabine works in treating patients with recurrent bladder cancer that has progressed despite previous Bacillus Calmette-Guerin (BCG).

Bladder Cancer

SWOG Cancer Research Network58 participantsStarted Nov 2006

Little Rock, Arkansas, United States • Los Angeles, California, United States • Leesburg, Florida, United States +95 more locations

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin

Find Trials by Condition in Detroit

Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer

A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy

Platelet Derived Growth Factor Stimulates Bone Fill and Rate of Attachment Level Gain

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)

Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer

Safety and Tolerability of Glatiramer Acetate

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma

Pain Control In First Trimester Medical Abortion: A Randomized Trial

Parent-Based Treatment for Pediatric Overweight

Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome

Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

Understanding Sleep Problems in Children With Autism Spectrum Disorder

Clinical Trial of a Silver Eluting Dressing System